Anu Hoey

An open letter from female biotech leaders on Post-Roe America. Signed by 65 executives and counting. CC @SulimanShehnaaz @juliacowens timmermanreport.com/2022/07/an-ope…

Join us at this year’s @IAmBiotech International Convention in San Diego, CA. We look forward to connecting with our #Biotech peers and exploring potential opportunities with new partners. Learn more here: bit.ly/3wPO2hI #Bio2022

nytimes.com/2022/06/05/hea… “I believe this is the first time this has happened in the history of cancer.” Rectal tumors disappeared in every patient

🙌🏽 watch this as much as you watch the game tonight….

We’re looking for #scientists, #engineers & #entrepreneurs who share our mission of building a new path forward to improve human health span. If you are passionate about innovation, technology & aging research see here: bit.ly/3o5q273 #careers #hiring

We are pleased to welcome @anuhoey as Chief Business Officer. Learn more about how her expertise will help support our next phase of growth as we advance our pipeline of therapeutics here: bit.ly/3A7FhRw

Last week, our interns shared the work they did this summer. As we say goodbye, we are reflecting on the passion, energy and curiosity they added to our team's work. We wish them good luck and a heartfelt congratulations on a job well done. #Biotech #BiotechInterns #BostonBiotech

Exciting news! Sensei Bio will extend our commitment to #ImmunoPhage by collaborating with @WUSTLmed and leading immunologist, Robert Schreiber, Ph.D., to explore fundamental immunological processes that utilize neoantigens and identify therapeutic opportunities in #cancer.

Sensei Bio today announced new data from the ongoing Phase 1/2 combination clinical trial of SNS-301, an investigational medicine in patients with advanced #SquamousCellCarcinoma of the head and neck. The data will be presented in a poster at #ASCO21. bit.ly/3wleD4q

At Sensei Bio, we’re developing a pipeline of medicines designed to fulfill the substantial potential of the #ImmuneSystem to defeat #cancer. #ImmunoTherapy #ImmunoOncology #Oncology #ImmunoPhage #ASCO21 bit.ly/SenseiBioMissi…

With the ability to design product candidates in a modular fashion, Sensei believes our ImmunoPhage™ platform has the potential to deliver personalized, off-the-shelf product candidates tailored to a patient’s specific tumor. #personalizedimmunotherapy senseibio.com/scientific-pla…

Sensei is developing ready-made, clinical-grade bacteriophage vaccines, covering the cancer antigen landscape. From this library, we will create personalized vaccines, tailored to a cancer patient’s specific antigen profile. #personalizedimmunotherapy #immunophage" target="_blank" rel="nofollow noopener">senseibio.com/scientific-pla…

Sensei Biotherapeutics is working to develop immunotherapies that have the potential to alter the treatment landscape and contribute value to patients and society. #Phageimmunotherapy #personalizedimmunotherapy #pipeline-row" target="_blank" rel="nofollow noopener">senseibio.com/pipeline/#pipe…

Friendly reminder. Lindsey Graham argued and voted to convict a President for lying about sex. Fast forward....Trump. And he’s just fine with all of it. The lying. The incitement to violence. The abuse of the office for political purposes. All of it.

CONGRATULATIONS to cancer vaccine company Sensei Bio on their successful IPO today! Sensei reengineers the badass bacteriophage into a personalized vaccine for tough human cancers: senseibio.com $SNSE #WorldCancerDay reminds us of the need: worldcancerday.org/why-cancer

Today marks the start of our first week trading on Nasdaq as $SNSE. Congratulations and thank you to all who have helped us reach this important milestone. Onward and upward! senseibio.com

On #WorldCancerDay, we're proud to welcome Sensei Biotherapeutics, now trading under $SNSE. Sensei is working to discover and develop new personalized immunotherapy medicines to defeat cancer. Congratulations to the newly #NasdaqListed @SenseiBio team! 🎉

On #WorldCancerDay, we salute the healthcare workers, researchers, patients and families who fight cancer every day.

Sensei Biotherapeutics Announces Pricing of Upsized Initial Public Offering senseibio.com/sensei-biother…

Retweet if you think Ted Cruz and Josh Hawley should resign immediately.